Build Mode

Making life (and death) better despite regulatory barriers

Dec 18, 2025
Gabriel Sanchez, CEO of Enspectra Health and a Stanford innovator, discusses his journey developing a groundbreaking FDA-approved skin imaging device, emphasizing the challenges of regulatory navigation. Tom Harries, co-founder of Earth Funeral, shares insights on building a human composting service while tackling the cultural taboos of death and regulatory hurdles. Both founders offer tactical advice on securing funding in regulated spaces and adapting their strategies through lengthy approval processes, highlighting the importance of education and advocacy in their industries.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

From Stanford Lab To Fast 510(k) Clearance

  • Gabriel traced InSpectra from a Stanford lab invention through licensing, prototyping, and a Series A that shifted focus to regulatory work.
  • After four years of trials and documentation they submitted a 510(k) and received clearance in just over three months.
ADVICE

Design For Reimbursement From Day One

  • Align regulatory pathway with reimbursement strategy early to avoid post-clearance commercial dead-ends.
  • Consider hybrid approaches to leverage predicates and existing CPT codes to accelerate payment pathways.
ADVICE

Use Q-Subs To Lock Strategy Early

  • Use FDA pre-submission (Q-sub) meetings to plot strategy and get buy-in before costly trials.
  • Prepare a complete plan and evidence, don't ask the FDA to design your study for you.
Get the Snipd Podcast app to discover more snips from this episode
Get the app